Replies to post #34201 on Humanigen Inc (HGENQ)

[DonDonDonDon]

has management ever come out and said this is different from rolling review?

Humanigen today announced its submission for Marketing Authorization for lenzilumab in COVID-19, begun in June 2021, has been accepted by the United Kingdom’s (UK’s) Medicines and Healthcare Products Regulatory Agency (MHRA) for expedited COVID-related rolling review, with assessment expected to occur more rapidly than a standard rolling review.

https://ir.humanigen.com/English/news/news-details/2021/UKs-MHRA-accepts-Humanigens-submission-of-Lenzilumab-for-Marketing-Authorization-in-COVID-19-for-expedited-rolling-review/default.aspx